Pages

Thursday, August 22, 2013

TissueTech, Inc. Receives $10 Million in Growth Equity Financing

... platform. The Company has pioneered the clinical application of human amniotic membrane and its role in stem cell research. The Company's first product, AmnioGraftTM, is the only tissue graft designated by the FDA as homologous for promoting ...

http://www.vcaonline.com/news/news.asp?ID=2013082208

No comments:

Post a Comment